Nektar TherapeuticsNKTRNASDAQ
Loading
Capital Expenditure Over TimeExpanding
Percentile Rank100
Studio
Year-over-Year Change

Cash spent on acquiring or upgrading physical assets

Latest
$-171000.00
↑ 98% vs avg
Percentile
P100
Near historical high
Streak
1 yr
Consecutive growthExpanding
Average
$-8.70M
Historical baseline
PeriodValueYoY Change
TTM$-171000.00+88.4%
2024$-1.47M-69.7%
2023$-865000.00+84.8%
2022$-5.68M+62.1%
2021$-14.99M-106.5%
2020$-7.26M+72.4%
2019$-26.29M-84.6%
2018$-14.24M-47.2%
2017$-9.68M-51.4%
2016$-6.39M-